Biostar Pharmaceuticals, Inc.
BSPM
BSPM was delisted on the 18th of September, 2018.
9 hedge funds and large institutions have $836K invested in Biostar Pharmaceuticals, Inc. in 2015 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
29% more funds holding
Funds holding: 7 → 9 (+2)
7% more capital invested
Capital invested by funds: $780K → $836K (+$56K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$33.8K |
| 2 |
ISB
Iowa State Bank
Urbandale,
Iowa
|
+$14.2K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$12.8K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$233 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIM
Spark Investment Management
New York
|
-$22K |
| 2 |
Morgan Stanley
New York
|
-$11.5K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$5.36K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.08K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $772K | +$33.8K | +4,200 | +5% |
|
2
California Public Employees Retirement System
Sacramento,
California
| $15K | – | – | – |
|
|
ISB
3
Iowa State Bank
Urbandale,
Iowa
| $15K | +$14.2K | +1,769 | New |
|
|
VKH
4
Virtu KCG Holdings
New York
| $14K | +$12.8K | +1,593 | New |
|
|
5
Citadel Advisors
Miami,
Florida
| $12K | -$5.36K | -667 | -31% |
|
|
6
UBS Group
Zurich,
Switzerland
| $7K | -$1.08K | -134 | -15% |
|
7
Bank of America
Charlotte,
North Carolina
| $1K | – | – | – |
|
|
SIM
8
Spark Investment Management
New York
| – | -$22K | -2,786 | Closed |
|
|
9
Morgan Stanley
New York
| – | -$11.5K | -1,428 | -98% |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| – | +$233 | +29 | New |
|
BSPM Hedge Fund Activity: Q1 2015 in Review
9 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Biostar Pharmaceuticals, Inc. (BSPM) for Q1 2015, worth a combined $836K — up 7.2% from $780K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new BSPM positions and 1 closed out — a net gain of 2 holders — while 1 added to existing stakes and 3 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $33.8K. The largest seller was Spark Investment Management, exiting entirely with an estimated $22K sold.
- 9 institutional investors held Biostar Pharmaceuticals, Inc. (BSPM) as of Q1 2015, up from 7 in Q4 2014.
- Funds reported $836K of Biostar Pharmaceuticals, Inc. stock for Q1 2015, up 7.2% quarter-over-quarter.
- 3 funds opened new Biostar Pharmaceuticals, Inc. positions in Q1 2015 and 1 closed out, a net change of +2 holders.
- The largest Biostar Pharmaceuticals, Inc. buyer in Q1 2015 was Renaissance Technologies, an estimated $33.8K added.
- The largest Biostar Pharmaceuticals, Inc. seller in Q1 2015 was Spark Investment Management, an estimated $22K sold.
Based on aggregated 13F filings for Q1 2015.